Skip to content
10-Q

Quarterly Report

Regenicin, Inc.

0001662252-23-000012

← back to feed
Filed
Feb 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jan 20, 2023 153.48M sh
Shares Diluted Q1 2023 · Dec 31, 2022 153.48M sh
Shares Diluted Q1 2023 · Dec 31, 2021 153.48M sh
Current Liabilities Q1 2023 · Dec 31, 2022 $17.67M
Total Assets Q1 2023 · Dec 31, 2022 $11.79M
Eps Diluted Q1 2023 · Dec 31, 2022 $0.00
Eps Diluted Q1 2023 · Dec 31, 2021 $0.00
Eps Basic Q1 2023 · Dec 31, 2022 $0.00
Eps Basic Q1 2023 · Dec 31, 2021 $0.00
Sga Expense Q1 2023 · Dec 31, 2022 $267.62K
Operating Cash Flow Q1 2023 · Jun 30, 2022 −$361.79K
Operating Cash Flow Q1 2023 · Jun 30, 2021 −$10.63K
Net Income Q1 2023 · Jun 30, 2022 −$277.51K
Net Income Q1 2023 · Jun 30, 2021 −$154.13K